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OBJECTIVES: To characterise the productivity loss of patients
with depression and concurrent pain as reported from the
Factors INﬂuencing Depression Endpoints Research (FINDER) 6
month observational study in the UK. METHODS: Patients were
enrolled in the FINDER study funded by Eli Lilly and Boehringer
Ingelheim primarily evaluating health-related quality of life in
patients seeking treatment for depression. Occupational status
and working pattern data were collected at enrolment and sub-
sequent observations at 3 and 6 months. Pain was assessed using
a visual analogue scale (range 0–100, no/mild pain [NMP]
0–30 mm, signiﬁcant pain >30 mm). RESULTS: A total of 608
patients were enrolled with a mean age of 42.8 years (SD 14.7)
and 61.2% were female. Of these, 349 (57.6%) patients were
employed 35.8 hours a week (SD 11.9). At baseline, 38.7% of
those working missed an average 41.7 (SD 33.1) hours of
employment over the previous 2 weeks. 62.6% of patients with
NMP were employed compared to 54.6% of patients with sig-
niﬁcant pain with a medical disorder not known to cause pain or
without further co-morbidity (PD); and 46.9% of patients with
signiﬁcant pain and a co-morbid medical condition known to
cause pain. At 3 and 6 month observations, the number of
patients who reported to have missed paid work during the last
2 weeks showed improvement in all 3 pain cohorts. However,
more patients with PD reported work missed relative to the other
cohorts at each observation. Furthermore, patients with PD also
reported a greater number of hours of employment missed during
the last 2 weeks. CONCLUSION: Workplace productivity was
increased relative to baseline for these patients with depression
following 6 months of antidepressant treatment. Despite
improvements in workplace attendance, they continued to report
workplace absenteeism, particularly those with concurrent pain
of unknown aetiology.
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OBJECTIVES: Various behavioural symptoms occur during the
course of dementia. Despite, many previous studies have dem-
onstrated the global inﬂuence of behavioural symptoms on the
total cost of care, the inﬂuence of individual behavioural symp-
toms on individual resource use remains unclear. The objective
of the study was to determine which symptom has more inﬂu-
ence on which resource use, looking if some symptoms or
groups of symptoms are often associated with a higher use of
resources. METHODS: This study was an analysis of a cohort
including 349 dementia patients living in France. The follow-up
of patients consists in one demographic and clinical question-
naire at baseline and resources use questionnaires at baseline, 6
months and 12 months. The resource use will be described in
general population and then according to the presence or
absence of behavioural symptoms. RESULTS: Description of
resources use in general population was consistent with what
was observed in other studies (on average 3 GP visits, 1 spe-
cialist visit, 4 physiotherapist visits, 1 psychologist visit and 30
nurse visits during the last quarter), which seems to validate
data collection. At the opposite, we noticed a signiﬁcant inﬂu-
ence of some behavioural symptoms on long-term health care
i.e. antipsychotic treatments and social services. Actually, antip-
sychotic treatments were more frequent on patients with delu-
sion (+26%), hallucination (+25%), agitation (+13%) or
irritability (+10%). The proportion of patients in home for
elderly was higher in patients with delusion (+23%), hallucina-
tion (+20%), agitation (+11%) and anxiety (+11%). CON-
CLUSION: No obvious inﬂuence of speciﬁc behavioural
symptoms on acute care like hospitalisation was shown; it
could be easily explained by the delay between behavioural and
resource use assessments. Behavioural symptoms as delusion,
hallucination and agitation were the symptoms the most fre-
quently associated with long-term resources use.
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OBJECTIVES: Estimate comorbidities, metabolic control and
costs (resource utilization) associated with depressive syndrome
in patients with stroke in a primary care setting, in routine
clinical practice. METHODS: Multicentric retrospective study.
Data were obtained from medical records of 5 primary care
centres during 2006. Comparative cohort: patient without
depression. Main variables: sex, age, general comorbidities,
Charlson index (severity), clinical parameters (Body mass index
[BMI], blood pressure, glucose levels, cholesterol, HDLc and
LDLc, among other) and total costs per patient/year. Resource
utilization: medical visits, diagnostic/therapeutic test, specialist
referrals and pharmaceutical prescription. An ANCOVA analysis
was performed (Bonferroni adjust) to correct the costs’ model.
SPSSWIN program was used, with a statistical signiﬁcance of
p < 0.05. RESULTS: In all, 63,525 patients were evaluated; 4.0%
(CI95%:3.8–4.2%) had stroke (n = 2,566); their mean age was
70.1  13.4 years old and 42.2% were women. A 17.7% had
depression, with 69.5  12.6 years old as average age and a
57.2% of women. Depression was not signiﬁcantly associated
with age, general comorbidities, Charlson index and clinical
parameters of metabolic control. Patients with depression had a
greater BMI than the comparative cohort (29.2 vs. 28.4 Kg/m2,
respectively; p = 0.003). Depression in stroke patients was
associated with a greater utilization of resources: medical
visits (14.9  13.9 vs. 17.7  17.3; p < 0.001); diagnostic
tests (1.6  4.2 vs. 2.1  4.7; p = 0.03); specialist referrals
(106.0  145.5 vs. 140.7  184.3; p < 0.001) and drug prescrip-
tions (€1092  1 084 vs. €1527  €1268; p = 0.000). After age,
sex and comorbidity correction, the presence depression in stroke
patients was associated with higher costs: €1498 vs. €2038,
p < 0.001. CONCLUSION: In a primary care setting, the pres-
ence of depression in patients with stroke showed an increased
prevalence. It is clear that there is a greater use of health resource
utilization in these type of patients that derives in higher cost.
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